Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

60.43
+0.27000.45%
Volume:108.10K
Turnover:6.51M
Market Cap:5.84B
PE:-12.84
High:60.55
Open:60.19
Low:59.61
Close:60.16
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.38
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.70
PE(LYR):-13.85

Loading ...

Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 05, 2024

Major Issues Report

Form 8-K - Current report